News
-
Cracking the Puzzle of Lower Respiratory Tract Infections in Children
CZ Biohub SF researchers and colleagues leverage genomics and machine learning to better diagnose LRTI, a major killer of children worldwide
-
An Age-Old Battle: Scientists Uncover What Makes Malaria Such a Wily Foe
A new study by researchers at CZ Biohub SF and UCSF points the way to a better vaccine design
-
Here’s why we’re opening a new research center in Chicago
CZI co-CEO and Co-Founder Priscilla Chan reflects on the organization’s progress in science, which is changing lives and opening extraordinary new horizons in medicine.
-
A cartography of human histology is in the making
It will identify and locate every type of cell in the human body.
-
CZ Biohub San Francisco Announces New Cohort of Physician-Scientist Fellows
Program provides a critical entry point for medical doctors interested in scientific research
-
Uncommon test solved a Mission medical mystery
Metagenomic sequencing can be a cutting edge strategy to diagnose patients
-
A CZ science team member shares her hopes for the future
A parent, artist and volunteer, get to know Sandra Moreno and her integral role as an executive assistant for CZI’s science program.
-
Mark Zuckerberg And Priscilla Chan On Their New ‘Biohub’ In Chicago
[Forbes] How they plan to spend billions to help others cure or manage disease
-
New Chan Zuckerberg Biohub Chicago Will Engineer Technologies to Measure Human Biology
Research hub brings together leading institutions to build sensors to study inflammation, a major driver of disease
-
Group founded by Mark Zuckerberg to spend $250 million on new Chicago biotech hub, with researchers from Northwestern, UChicago, and UIUC
-
Lafora disease: A ‘particularly cruel’ form of epilepsy
Learn about Lafora disease — a severe form of epilepsy that impacts adolescents — and the researchers partnering with patients to find a cure.
-
PRINT How An Early Warning Radar Could Prevent Future Pandemics
A tool called metagenomic sequencing can help detect unknown pathogens, but widespread use faces challenges.